Page 32 - 南京医科大学学报社会科学版

南京医科大学学报（社会科学版）京医科大学学报（社会科学版） 第4期 总第111期
南
· 342 · Journal of Nanjing Medical University（Social Sciences）of Nanjing Medical University（Social Sciences） 2022年8月
Journal
fectious biological agents，infectious substances，and ［10］ 高鹏飞，戴晓理，刘德臣，等. 入境特殊物品全流程监
vectors［EB/OL］.［2021- 04- 05］. https：//www.ecfr.gov/ 管模式创新研究［J］. 物流技术，2016，35（5）：12-15，33
current/title⁃42/chapter⁃I/subchapter⁃F/part⁃71/subpart⁃F/ ［11］ 王军志. 我国生物药监管科学的发展概述［J］. 中国新
section⁃71.54 药杂志，2018，27（21）：2465-2471
［7］ Centers for Disease Control and Prevention. Frequently ［12］ 冯栎竹，曹文泽. 进境生物材料检疫监管模式［J］. 北
asked questions concerning import permits：inspection 京农业，2013（27）：1
questions［EB/OL］.［2021-11-05］. http：//www.cdc.gov/ ［13］ 陈一飞，李香玉，陈桂良. 监管科学在促进生物医药产
od/eaipp/faq.htm 业发展中的作用［J］. 上海医药，2020，41（13）：10-14
［8］ CDC Federal Select Agent Program. Select agents over⁃ ［14］ 畅琦. 新海关出入境特殊物品卫生检疫监管探讨［J］.
view［EB/OL］.［2021-11-05］. https：//www.selectagents. 口岸卫生控制，2018，23（6）：1-3，6
gov/overview/index.htm ［15］ 刘世福. 新海关出入境特殊物品卫生检疫监管策略探
［9］ 王子灿. 生物安全法对生物技术风险与微生物风险的 析［J］. 大众标准化，2020（20）：234-235
法律控制［M］. 北京：法律出版社，2015：131-137 （本文编辑：姜 鑫）

Study on whole chain management mode of imported high⁃risk special

products

2
1
1
2
XU Yilin ，FU Liyuan ，WENG Yunqi ，SUN Tao ，WU Jingxian 1
1. Suzhou Industrial Park Customs，Suzhou 215000；2. Nanjing Customs，Nanjing 210000，China
Abstract：Under the background of the rapid development of the biopharmaceutical industry and the sharp
increasing import and export volume of special products with the complex situation of the pandemic of COVID⁃
19，this article introduces and compares the supervision mechanism of import and export of special products in
China and the United States in detail. It analyzes the legislative loopholes，information silos，regulatory blind
spots，regulatory gaps and detection difficulties in the supervision of special products in China. Accordingly，we
propose to establish a whole⁃chain management model for high⁃risk special inbound products in China. On the
premise of ensuring the safety supervision of high⁃risk special products，we suggest to explore and promote the
establishment of laws that are compatible with the domestic and international biosecurity situation and the
supervision needs of special products. In addition to this，we also recommend to cooperate with multiple
departments to optimize and improve the supervision mechanism of special products after the entry. With above
measures we can effectively solve the difficulties of entry inspection of special products and supervision blind
spots，and improve the level of customs clearance facilitation，thus making the supervision of the entry of high⁃
risk special products more complete and efficient to support the biopharmaceutical industry become bigger and
stronger with scientific regulation.
Key words：special products；import and export policy；whole chain management mode